+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
1026987-94-9,MFCD28898588
Catalog No.:AA00082D

1026987-94-9 | L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$162.00   $114.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00082D
Chemical Name:
L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
CAS Number:
1026987-94-9
Molecular Formula:
C23H40N2O9
Molecular Weight:
488.5717
MDL Number:
MFCD28898588
SMILES:
OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@H](C(=O)OC(C)(C)C)CCC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
743  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
16  
XLogP3:
2.3  

Downstream Synthesis Route

[1]JournalofDrugTargeting,2013,vol.21,p.968-980

[2]Patent:US2018/99934,2018,A1

[3]MolecularPharmaceutics,2018,vol.15,p.1842-1852

[4]AngewandteChemie-InternationalEdition,2018,vol.57,p.12733-12736    Angew.Chem.,2018,vol.130,p.12915-12918,4

[5]Patent:WO2019/57964,2019,A1

[1]Patent:WO2013/22797,2013,A1.Locationinpatent:Page/Pagecolumn69

[1]Patent:WO2015/69766,2015,A1.Locationinpatent:Paragraph00218

[1]Patent:WO2015/69766,2015,A1

H-cysteine(trityl)-2-chlorotritylresin 
  1026987-94-9    35661-40-6    71989-14-5    131570-56-4    126631-93-4    1025066-50-5 

[1]JournalofMedicinalChemistry,2015,vol.58,p.3094-3103

Literature

Title: Roy J, et al. DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selectiveprostate cancer cell targeting. J Med Chem. 2015 Apr 9;58(7):3094-103.

Title: Lv Q, et al. Prostate-Specific Membrane Antigen Targeted Therapy of Prostate Cancer Using a DUPA-Paclitaxel Conjugate. Mol Pharm. 2018 May 7;15(5):1842-1852.

Title: Peng ZH, et al. Spacer length impacts the efficacy of targeted docetaxel conjugates in prostate-specificmembrane antigen expressing prostate cancer. J Drug Target. 2013 Dec;21(10):968-80.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 1026987-94-9
1025796-31-9

1025796-31-9
Building Blocks
More >
Tags:1026987-94-9 Molecular Formula|1026987-94-9 MDL|1026987-94-9 SMILES|1026987-94-9 L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
Catalog No.: AA00082D
1026987-94-9,MFCD28898588
1026987-94-9 | L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
Pack Size： 250mg
Purity： 98%
in stock
$162.00 $114.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00082D
Chemical Name: L-Glutamic acid, N-[[[(1S)-3-carboxy-1-[(1,1-dimethylethoxy)carbonyl]propyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
CAS Number: 1026987-94-9
Molecular Formula: C23H40N2O9
Molecular Weight: 488.5717
MDL Number: MFCD28898588
SMILES: OC(=O)CC[C@@H](C(=O)OC(C)(C)C)NC(=O)N[C@H](C(=O)OC(C)(C)C)CCC(=O)OC(C)(C)C
Properties
Complexity: 743  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 2  
Heavy Atom Count: 34  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 3  
Rotatable Bond Count: 16  
XLogP3: 2.3  
Downstream Synthesis Route
105590-97-4    1026987-94-9 

[1]JournalofDrugTargeting,2013,vol.21,p.968-980

[2]Patent:US2018/99934,2018,A1

[3]MolecularPharmaceutics,2018,vol.15,p.1842-1852

[4]AngewandteChemie-InternationalEdition,2018,vol.57,p.12733-12736    Angew.Chem.,2018,vol.130,p.12915-12918,4

[5]Patent:WO2019/57964,2019,A1

53838-27-0    1026987-94-9    1422159-11-2 

[1]Patent:WO2013/22797,2013,A1.Locationinpatent:Page/Pagecolumn69

1026987-94-9   
C41H33ClNO2PolS 
  35661-40-6    71989-14-5    131570-56-4    126631-93-4    1025066-50-5 

[1]Patent:WO2015/69766,2015,A1.Locationinpatent:Paragraph00218

16874-06-9    105590-97-4    1026987-94-9 

[1]Patent:WO2015/69766,2015,A1

H-cysteine(trityl)-2-chlorotritylresin 
  1026987-94-9    35661-40-6    71989-14-5    131570-56-4    126631-93-4    1025066-50-5 

[1]JournalofMedicinalChemistry,2015,vol.58,p.3094-3103

Related Products of of 1026987-94-9
1025796-31-9
1025796-31-9
Building Blocks More >
1134524-25-6
1134524-25-6
1-(4-Fluorophenyl)cyclopropan-1-amine hydrochloride
AA0008KF | MFCD07995728
113710-34-2
113710-34-2
2-((3-(Trifluoromethyl)phenyl)amino)ethene-1,1,2-tricarbonitrile
AA0009C4 | MFCD00129440
113967-71-8
113967-71-8
7-Amino-2-(methylsulfanyl)[1,2,4]triazolo[1,5-a]pyrimidine-6-carboxylic acid
AA000A4M | MFCD00067817
1142197-14-5
1142197-14-5
2-Bromo-5-cyclopropylpyridine
AA000ARI | MFCD11869551
1160246-99-0
1160246-99-0
tert-Butyl 3-(aminomethyl)-2-oxa-9-azaspiro[5.5]undecane-9-carboxylate
AA000BBI | MFCD12198537
116128-29-1
116128-29-1
Diacetato[(R)-(+)-2,2'-bis(di-p-tolylphosphino)-1,1'-binaphthyl]ruthenium(II)
AA000BN0 | MFCD09753021
1163693-01-3
1163693-01-3
2-Chloro-3-iodo-4-methoxypyridine
AA000C8S | MFCD18415710
116632-47-4
116632-47-4
3-Propylpyrrolidine
AA000CUA | MFCD07383545
116903-46-9
116903-46-9
1-Ethoxy-4-[2-(4-methylphenyl)ethynyl]benzene
AA000D9X | MFCD01817758
1170884-07-7
1170884-07-7
2-Chloro-6-fluoro-benzamidine HCl
AA000DMC | MFCD04114429
Submit
© 2017 AA BLOCKS, INC. All rights reserved.